Platepag ML 50mg Tablet
Marketer
Metta Life Sciences Private Limited
Salt Composition
Eltrombopag (50mg)
Overview Platepag ML 50mg Tablet
Thrombopoietin receptor agonist Platepag ML 50mg tablets counter low platelet counts stemming from chronic immune thrombocytopenic purpura (ITP), including idiopathic forms, or chronic hepatitis C (HCV). This medication also addresses severe aplastic anemia. By stimulating platelet production, it mitigates bleeding risks. Adhere strictly to your physician's prescribed dosage and regimen; it can be taken on an empty stomach. Swallow the tablet whole; avoid crushing, chewing, or breaking it. Report any allergies to this medication. Common adverse effects include nausea, vomiting, diarrhea, upper respiratory infections, and urinary tract infections. Discuss any bothersome side effects with your doctor; management strategies are available. Always disclose pre-existing health issues and all concurrently used medications before commencing treatment. Liver impairment may necessitate dosage adjustments, so inform your doctor accordingly.
Uses of Platepag ML 50mg Tablet
Thrombocytopenia resulting from immune thrombocytopenic purpura or hepatitis C; management of critical bone marrow failure.
Major Benefits of Platepag ML 50mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Platepag ML 50mg Tablets should be administered on an empty stomach.
Common Side effects of Platepag ML 50mg Tablet:
- Nausea
- Diarrhea
- Upper respiratory tract infection
- Vomiting
- Increased liver enzymes
- Muscle pain
- Urinary tract infection
How to use Platepag ML 50mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Platepag ML 50mg Tablet on an empty stomach.
How Platepag ML 50mg Tablet works:
Mlplate 50mg tablets contain a thrombopoietin receptor activator. This medication boosts platelet production, thus lessening or preventing excessive bleeding.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Platepag ML 50mg Tablet lacks established safety data. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Platepag ML 50mg Tablets during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Patient consultation with their doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
The use of Platepag ML 50mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving may be impaired by Platepag ML 50mg Tablet, which can induce dizziness and reduced alertness, impacting safe operation of a vehicle.
KidneySAFE IF PRESCRIBED
Platepag ML 50mg tablets can be used by patients with kidney disease without altering the prescribed dosage. Nevertheless, disclosure of kidney disease to your physician is essential. Routine monitoring of kidney function is recommended during treatment with this medication.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Platepag ML 50mg tablets. Dosage modification of Platepag ML 50mg tablets may be necessary. Physician consultation is recommended.
What if you forget to take Platepag ML 50mg Tablet :
Omit any missed Platepag ML 50mg Tablet dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Platepag ML 50mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Biphenyl Derivatives |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Actions | Thrombopoietin stimulator |
3,018 People bought this recently